Your browser doesn't support javascript.
loading
Autoimmune hemolytic anemia and thrombocytopenia in a Chinese patient with heterozygous NBAS mutations: Case report.
Yang, Yuanlin; Fei, Xiaoming; Lei, Fang; Wang, Lixia; Yu, Xianqiu; Tang, Yu.
Afiliación
  • Yang Y; Department of Hematology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Fei X; Department of Hematology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Lei F; Department of Hematology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Wang L; Department of Hematology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Yu X; Department of Hematology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Tang Y; Department of Rheumatology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Medicine (Baltimore) ; 103(12): e36975, 2024 Mar 22.
Article en En | MEDLINE | ID: mdl-38517998
ABSTRACT
RATIONALE Neuroblastoma amplified sequence (NBAS)-associated disease is an autosomal recessive disorder and a broad spectrum of clinical symptoms has been reported. However, autoimmune mediated hemolytic anemia (AIHA) is rarely reported in NBAS disease. PATIENT CONCERNS A now 21-year-old male harbors heterozygous variants of c.6840G>A and c.335 + 1G>A and was found had retarded growth, hypogammaglobulinemia, B lymphopenia, optic atrophy, horizontal nystagmus, slight splenomegaly and hepatomegaly since childhood. This case had normal hemoglobin level and platelet count in his childhood. He developed AIHA first in his adulthood and then thrombocytopenia during the treatment of AIHA. The mechanism underlying a case with pronounced hypogammaglobulinemia and B lymphopenia is elusive. In addition to biallelic NBAS mutations, a germline mutation in the ANKRD26 (c.2356C>T) gene was also detected. So either autoimmune or ANKRD26 mutation-mediated thrombocytopenia is possible in this case. INTERVENTION AND

OUTCOME:

He was initially managed with steroid and intermittent intravenous immunoglobulin supplement. After treatment, he responded well with a normalization of hemoglobin and serum bilirubin. But the patient subsequently experienced severe thrombocytopenia in addition to AIHA. He was then given daily avatrombopag in addition to steroid escalation. He responded again to new treatment, with the hemoglobin levels and platelet counts went back to the normal ranges. Now he was on de-escalated weekly avatrombopag and low-dose steroids maintenance.

CONCLUSION:

The phenotype of this case indicates that c.335 + 1G>A NBAS variant is probably a pathogenic one and c.2356C>T ANKRD26 variant is improbably a pathogenic one. AIHA may respond well to steroid even when happened in patients with NBAS disease.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiazoles / Tiofenos / Trombocitopenia / Agammaglobulinemia / Anemia Hemolítica Autoinmune / Linfopenia / Neuroblastoma Límite: Adult / Child / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiazoles / Tiofenos / Trombocitopenia / Agammaglobulinemia / Anemia Hemolítica Autoinmune / Linfopenia / Neuroblastoma Límite: Adult / Child / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2024 Tipo del documento: Article País de afiliación: China